Abstract
Despite the availability and implementation of well-known efficacious interventions for Tuberculosis (TB) prevention and treatment by the Ministry of Health, Uganda (MoH), treatment non-adherence persists. Moreover, identifying a specific patient at risk of non-adherence is still a challenge. Thus, this study set out to utilize machine learning modeling to explore individual risk factors predictive of tuberculosis treatment non-adherence in the Mukono district.
This was a retrospective study based on a record review of 838 TB patients enrolled in six health facilities (3 government, 3 private-not-for-profit) in the Mukono district. We developed five machine learning algorithms (Logistic regression (LR), artificial neural networks (ANN), support vector machines (SVM), Random Forest (RF), and AdaBoost) to explore the individual risk factors for tuberculosis treatment non-adherence. Also, we evaluated their accuracy by computing the positive predictive value (PPV) and negative predictive value (NPV) through the aid of a confusion matrix.
Of the five developed and evaluated models, SVM performed the best with an accuracy of 91.28 % compared to RF (89.97%), LR (88.30%), ANN (88.30%), and AdaBoost (91.05%) respectively. Individual risk factors predictive of non-adherence included; TB type, GeneXpert results, sub-country, ART status, contacts below 5 years, health facility ownership, sputum test results at 2 months, treatment supporter, CPT Dapson status, risk group, patient age, gender, middle and upper arm circumference, referral, positive sputum test at 5 months and 6 months.
This study shows that classification machine learning techniques can identify patient factors predictive of treatment non-adherence and accurately differentiate between adherent and non-adherent patients. Thus, TB program management should consider adopting the machine learning techniques evaluated in this study as a screening tool for both identity and target-suited interventions for these patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Makerere University School of Public Health Institutional Review Board
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
